close
close

Nvidia, Alibaba, Novavax, Ryanair and Diageo

Jensen Huang, CEO of Nvidia (NVDA), unveiled details on a number of announcements on new technologies on Monday at Computerex Tech Expo in Taipei, Taiwan.

This included the presentation of Nvidia Isaac Gr00T-Dreams, which the company described as a blueprint that contributes to generating large amounts of synthetic movement data with which developers of Physical Artificial Intelligence (AI) can teach new behaviors.

Read more: FTSE 100 LIVE: Shave stocks as Great Britain and the EU that handle before the summit

In addition to the robotics functions, NVIDIA has presented its new NVLINK merger offer, with which customers can create custom server using the grace CPU from NVIDIA and an AI chip of third-party providers with the various server infrastructure offers from NVIDIA.

The Nvidia shares declined by 2.5% on Monday, although the share has recently achieved a greater performance and has increased by 29% last month.

Last week Huang said during an investment forum in Saudi Arabia, in which US President Donald Trump and other Big Tech -CEO were participated -that the chipmaker will send his semiconductors to Saudi -Arabische Artificial Intelligence Company Humain for his massive data center plans.

Nasdaqgs – delayed quote USD

At the end: May 16 at 4:00 p.m. GMT-4

The shares listed in Hong Kong on Alibaba (9988.hk) fell by 3%on Monday after a report on the weekend on which the Trump government had expressed concerns about a potential offer between the Chinese tech giant and the iPhone maker Apple (AAPL).

The New York Times reported on Saturday that the officers of the White House and the Congress tested Apple's plan to conclude a contract with Alibaba to provide their AI on Iphones in China.

Read more: Gold increases to Safe Haven Appeal as Moody's US credit aging

The spokesman for the White House, Alibaba and Apple had not answered the request of Yahoo Finance UK at the time of writing.

The report continued to load Alibaba shares that had dropped last week after the company's profit estimates.

According to a Reuters report, the income of 236.45 billion Yuan was under the expectations of 237.24 billion yuan (24.57 billion GBP). The adapted profit of 12.52 Yuan per American deposition also overlooked estimates of 12.94 Yuan.

The shares of the biotechnology company Novavax (NVAX) rose by 17% in pre-market trading on Monday after the US Food and Drug Administration (FDA) had approved its COVID 19 vaccine, albeit with certain conditions.

In a letter issued on Friday, the FDA said that the vaccine was approved for people aged 65 and over, and those who had at least one underlying disease that exposed it to a high risk of serious diseases from Covid.

Leave a Comment